BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 208 filers reported holding BRIDGEBIO PHARMA INC in Q2 2023. The put-call ratio across all filers is 0.75 and the average weighting 0.5%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 6,068,125 | $369,913,000 | 59.23% |
| Affinity Asset Advisors, LLC | 550,000 | $33,528,000 | 12.00% |
| Kohlberg Kravis Roberts & Co. L.P. | 31,060,971 | $1,893,477,000 | 7.68% |
| Perceptive Advisors | 15,513,856 | $945,724,000 | 6.14% |
| Opaleye Management Inc. | 517,150 | $31,525,000 | 5.24% |
| VIKING GLOBAL INVESTORS LP | 26,620,991 | $1,622,816,000 | 4.92% |
| Octagon Capital Advisors LP | 380,928 | $23,221,000 | 4.81% |
| Cormorant Asset Management, LP | 1,880,980 | $114,665,000 | 3.90% |
| HHLR ADVISORS, LTD. | 5,362,014 | $326,868,000 | 3.36% |
| Darwin Global Management, Ltd. | 336,817 | $20,532,000 | 3.31% |